Pfizer to acquire US biopharma company Arena Pharmaceuticals for $6.7bn
Pfizer has agreed to acquire Arena Pharmaceuticals, a publicly-listed clinical stage biopharma company based in the US, for about $6.7 billion. As per the terms of the deal, Pfizer will acquire all the shares of Arena Pharmaceuticals for $100 per share in cash. The deal has been unanimously approved by the boards of directors of […]